Company Profile
Vaccinex Stock Price, News & Analysis
- Ticker:
- VCNX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Vaccinex is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts.
Stock performance
0.83 USD (-24.58%)
Close
Last updated: June 23, 2026 at 00:00
—
Market cap
Why the stock is moving
VCNX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Vaccinex is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Vaccinex is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts.
Business Model Characteristics
Vaccinex combines program development with demand-sensitive launch execution, so investors usually track efficacy, safety, and the commercial path for each major asset.
Position Within the Biotechnology Landscape
Compared with broader biotech peers, Vaccinex sits in a catalyst-heavy corner of the landscape where virus, vaccine, and antiviral updates can move sentiment quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Vaccinex Announces Receipt of Delisting Notification from Nasdaq
Source: Vaccinex
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vaccinex (VCNX)?
Vaccinex (VCNX) most recently closed at 0.83 USD, a -24.58% move versus the previous session.
What does Vaccinex do?
Vaccinex is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
On which exchange is VCNX stock listed?
Vaccinex (VCNX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Vaccinex is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts., Biotechnology.
What is Vaccinex?
Vaccinex is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.
Which conditions is Vaccinex targeting with Vaccinex?
Vaccinex is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.